Abu Dhabi: SEHA, the largest integrated healthcare platform in the UAE and a subsidiary of PureHealth Group, has established a clinic at Sheikh Khalifa Medical City (SKMC) that specialises in treating Uveitis, an inflammatory eye disease, in pediatric patients.
The clinic employs a multi-disciplinary approach, with experts from SKMC’s rheumatology and ophthalmology departments collaborating to provide comprehensive care to patients. This coordinated approach ensures that patients receive faster treatment plans, accurate information, and fewer hospital visits, potentially improving outcomes for both vision and rheumatologic issues.
We are pleased to launch the new clinic at Sheikh Khalifa Medical City, dedicated to serving pediatric rheumatology. The clinic will help improve the average health span and promote a healthier lifestyle in Abu Dhabi and the UAE. Under the wise and visionary leadership of the country, SEHA aims to raise the benchmarks in healthcare excellence to world-class levels to drive efficiencies across the entire value chain.
Mr. Saeed Jaber Al Kuwaiti, Group Chief Executive Officer at SEHA, shared.
Pediatric Uveitis is a severe manifestation of rheumatological conditions, and early detection and treatment are essential to prevent blindness. Since its launch, the pediatric Uveitis clinic has treated patients, providing urgent diagnoses and treatment in a one-stop setting.
Dr. Noura Khalid Al Qassimi, Consultant Ophthalmologist at SKMC, remarked that “the option to provide combined care is very important, as reducing the time between diagnosis and treatment can significantly improve the child’s outcome. We want to avoid the risk of developing poor vision and blindness at all costs. Working together with our rheumatology department, we can together in the same setting agree on the diagnosis and management after explaining the whole situation to the parents and family and start the personalized treatment plan in order to save the child’s sight.”
Dr. Kamran Mahmood, Consultant Paediatric Rheumatologist at SKMC, commented that “we are now able to provide patients with specialist care for their inflammatory eye diseases, and the treatment strategies can then be discussed and initiated promptly. In these instances, time is of the essence, and now we’re positioned to deliver the best care possible.”